Volver a Agenda
Session Chair(s)
April N. Naegeli, DrPH, MPH
Senior Research Scientist, Global Patient Outcomes and Real World Evidence
Eli Lilly and Company, United States
Learning Objective : Review the strategic approach to using an innovative research model for validating a patient-reported outcome measure; Evaluate benefits and limitations associated with implementing a novel direct-to-patient approach to conducting this type of observational study; Define advantages of integrating multiple technologies and rapidly implementing lessons learned to maintain patient engagement.
Speaker(s)
Strategic Approach to Using an Innovative Research Model for Validating a Patient-Reported Outcome Measure
April N. Naegeli, DrPH, MPH
Eli Lilly and Company, United States
Senior Research Scientist, Global Patient Outcomes and Real World Evidence
Benefits and Limitations Associated With Implementing a Novel Direct-to-Patient Approach to Conducting a Validation Study
John Reites
THREAD, United States
Chief Executive Officer
Advantages of Integrating Multiple Technologies and Rapidly Implementing Lessons Learned to Maintain Patient Engagement
Brandon M. Wojtowicz
ERT, United States
Project Manager, eResearch Technology
¿Tiene una cuenta?